Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Publications resulting from research supported in whole or in part by this grant

Technical Report ·
DOI:https://doi.org/10.2172/5599513· OSTI ID:5599513
We have developed an infinite lifespan human fibroblast cell line after transfection of a v-{und myc} gene into human fibroblasts. The cells have normal morphology, have doubled more than 200 times since going through crisis, are not tumorigenic, and except for their infinite lifespan, are apparently normal. These cells can be converted into malignant cells by transfection and expression of a H-, N- or K-{und ras} oncogene. When {und finite} lifespan human fibroblasts are transfected with the same {und ras} gene constructions, the cells take on the same in vitro characteristics, but do not form tumors and they still retain the finite lifespan characteristic. Since the {und ras} and {und myc} oncogenes used to transfect the MSU-1.1 cells have normal proto-oncogene homologs in the human genome, it seems likely that it is these normal genes that become activated'' by carcinogen attack. We have undertaken the transfection studies to understand the role of various oncogenes in malignant transformation of human fibroblasts. With a knowledge of the phenotype caused by a specific oncogene, we can replace the transfection of a specific oncogene with carcinogen activation of the homologous gene. By proceeding in this way, we should be able to develop qualitative methods for the malignant transformation of human fibroblasts by carcinogens. 3 refs., 2 figs., 1 tab.
Research Organization:
Michigan State Univ., East Lansing, MI (USA)
Sponsoring Organization:
DOE/ER; DOHHS
DOE Contract Number:
FG02-87ER60524
OSTI ID:
5599513
Report Number(s):
DOE/ER/60524-2; ON: DE90001524
Country of Publication:
United States
Language:
English